Annual EBITDA:
-$396.44M+$723.62M(+64.61%)Summary
- As of today, ONC annual EBITDA is -$396.44 million, with the most recent change of +$723.62 million (+64.61%) on December 31, 2024.
- During the last 3 years, ONC annual EBITDA has risen by +$995.84 million (+71.53%).
- ONC annual EBITDA is now -12497.30% below its all-time high of -$3.15 million, reached on December 1, 2013.
Performance
ONC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$123.50M+$79.59M(+181.28%)Summary
- As of today, ONC quarterly EBITDA is $123.50 million, with the most recent change of +$79.59 million (+181.28%) on June 30, 2025.
- Over the past year, ONC quarterly EBITDA has increased by +$205.73 million (+250.19%).
- ONC quarterly EBITDA is now at all-time high.
Performance
ONC Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$89.25M+$205.73M(+176.63%)Summary
- As of today, ONC TTM EBITDA is $89.25 million, with the most recent change of +$205.73 million (+176.63%) on June 30, 2025.
- Over the past year, ONC TTM EBITDA has increased by +$879.97 million (+111.29%).
- ONC TTM EBITDA is now at all-time high.
Performance
ONC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ONC EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +64.6% | +250.2% | +111.3% |
| 3Y3 Years | +71.5% | +129.1% | +104.8% |
| 5Y5 Years | +57.9% | +135.2% | +105.8% |
ONC EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +77.0% | at high | +127.4% | at high | +104.9% |
| 5Y | 5-Year | at high | +77.0% | at high | +122.1% | at high | +104.7% |
| All-Time | All-Time | >-9999.0% | +77.0% | at high | +122.1% | at high | +104.7% |
ONC EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $123.50M(+181.3%) | $89.25M(+176.6%) |
| Mar 2025 | - | $43.91M(+250.5%) | -$116.48M(+70.6%) |
| Dec 2024 | -$396.44M(+64.6%) | -$29.18M(+40.4%) | -$396.44M(+45.5%) |
| Sep 2024 | - | -$48.97M(+40.4%) | -$727.23M(+8.0%) |
| Jun 2024 | - | -$82.23M(+65.2%) | -$790.72M(+21.3%) |
| Mar 2024 | - | -$236.06M(+34.4%) | -$1.00B(+10.3%) |
| Dec 2023 | -$1.12B(+35.0%) | -$359.98M(-220.1%) | -$1.12B(+7.5%) |
| Sep 2023 | - | -$112.46M(+62.1%) | -$1.21B(+20.4%) |
| Jun 2023 | - | -$296.38M(+15.6%) | -$1.52B(+7.7%) |
| Mar 2023 | - | -$351.25M(+22.1%) | -$1.65B(+4.4%) |
| Dec 2022 | -$1.72B(-23.8%) | - | - |
| Dec 2022 | - | -$450.61M(-6.7%) | -$1.72B(+5.9%) |
| Sep 2022 | - | -$422.16M(+0.4%) | -$1.83B(+1.5%) |
| Jun 2022 | - | -$423.94M(+0.6%) | -$1.86B(+2.1%) |
| Mar 2022 | - | -$426.69M(+23.6%) | -$1.90B(-36.4%) |
| Dec 2021 | -$1.39B(+14.4%) | -$558.62M(-24.1%) | -$1.39B(-6.2%) |
| Sep 2021 | - | -$450.15M(+2.8%) | -$1.31B(-1.4%) |
| Jun 2021 | - | -$463.31M(-680.6%) | -$1.29B(-9.5%) |
| Mar 2021 | - | $79.80M(+116.7%) | -$1.18B(+27.4%) |
| Dec 2020 | -$1.63B(-72.7%) | -$477.08M(-10.5%) | -$1.63B(-6.3%) |
| Sep 2020 | - | -$431.79M(-23.0%) | -$1.53B(-8.8%) |
| Jun 2020 | - | -$351.01M(+4.1%) | -$1.41B(-23.6%) |
| Mar 2020 | - | -$366.01M(+3.8%) | -$1.14B(-20.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$941.27M(-35.4%) | -$380.55M(-23.5%) | -$941.27M(-12.3%) |
| Sep 2019 | - | -$308.24M(-275.3%) | -$838.17M(-23.5%) |
| Jun 2019 | - | -$82.14M(+51.8%) | -$678.58M(+10.4%) |
| Mar 2019 | - | -$170.34M(+38.6%) | -$757.15M(-8.9%) |
| Dec 2018 | -$695.38M(-642.1%) | -$277.44M(-86.6%) | -$695.38M(-33.8%) |
| Sep 2018 | - | -$148.66M(+7.5%) | -$519.68M(-103.9%) |
| Jun 2018 | - | -$160.71M(-48.0%) | -$254.82M(-68.1%) |
| Mar 2018 | - | -$108.56M(-6.7%) | -$151.59M(-61.8%) |
| Dec 2017 | -$93.70M(+18.6%) | -$101.74M(-187.6%) | -$93.70M(-225.9%) |
| Sep 2017 | - | $116.20M(+302.2%) | -$28.75M(+84.0%) |
| Jun 2017 | - | -$57.48M(-13.4%) | -$179.28M(-22.9%) |
| Mar 2017 | - | -$50.68M(-37.7%) | -$145.93M(-26.7%) |
| Dec 2016 | -$115.15M(-108.6%) | -$36.80M(-7.2%) | -$115.15M(-9.0%) |
| Sep 2016 | - | -$34.32M(-42.2%) | -$105.67M(-24.8%) |
| Jun 2016 | - | -$24.14M(-21.3%) | -$84.64M(-29.2%) |
| Mar 2016 | - | -$19.89M(+27.2%) | -$65.50M(-18.7%) |
| Dec 2015 | -$55.20M(-288.7%) | -$27.32M(-105.4%) | -$55.20M(-74.1%) |
| Sep 2015 | - | -$13.30M(-166.2%) | -$31.70M(-20.5%) |
| Jun 2015 | - | -$5.00M(+47.9%) | -$26.31M(-23.4%) |
| Mar 2015 | - | -$9.59M(-151.5%) | -$21.31M(-81.9%) |
| Dec 2014 | -$14.20M(-351.2%) | -$3.81M(+51.7%) | -$11.72M(-48.3%) |
| Sep 2014 | - | -$7.90M | -$7.90M |
| Dec 2013 | -$3.15M | - | - |
FAQ
- What is BeOne Medicines Ltd. annual EBITDA?
- What is the all-time high annual EBITDA for BeOne Medicines Ltd.?
- What is BeOne Medicines Ltd. annual EBITDA year-on-year change?
- What is BeOne Medicines Ltd. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for BeOne Medicines Ltd.?
- What is BeOne Medicines Ltd. quarterly EBITDA year-on-year change?
- What is BeOne Medicines Ltd. TTM EBITDA?
- What is the all-time high TTM EBITDA for BeOne Medicines Ltd.?
- What is BeOne Medicines Ltd. TTM EBITDA year-on-year change?
What is BeOne Medicines Ltd. annual EBITDA?
The current annual EBITDA of ONC is -$396.44M
What is the all-time high annual EBITDA for BeOne Medicines Ltd.?
BeOne Medicines Ltd. all-time high annual EBITDA is -$3.15M
What is BeOne Medicines Ltd. annual EBITDA year-on-year change?
Over the past year, ONC annual EBITDA has changed by +$723.62M (+64.61%)
What is BeOne Medicines Ltd. quarterly EBITDA?
The current quarterly EBITDA of ONC is $123.50M
What is the all-time high quarterly EBITDA for BeOne Medicines Ltd.?
BeOne Medicines Ltd. all-time high quarterly EBITDA is $123.50M
What is BeOne Medicines Ltd. quarterly EBITDA year-on-year change?
Over the past year, ONC quarterly EBITDA has changed by +$205.73M (+250.19%)
What is BeOne Medicines Ltd. TTM EBITDA?
The current TTM EBITDA of ONC is $89.25M
What is the all-time high TTM EBITDA for BeOne Medicines Ltd.?
BeOne Medicines Ltd. all-time high TTM EBITDA is $89.25M
What is BeOne Medicines Ltd. TTM EBITDA year-on-year change?
Over the past year, ONC TTM EBITDA has changed by +$879.97M (+111.29%)